Posted in | News | Carbon Credit | Hydrogen

New CSIRO Company Pursues Hydrogen Game Changer for Heavy Industry

Australia’s national science agency, CSIRO, and corporate advisor RFC Ambrian have co-founded Hadean Energy, a new company to commercialise cutting-edge technology that can produce hydrogen with 30 per cent less electricity and help to decarbonise heavy industry.

CSIRO researchers Dr Gurpreet Kaur and Dr Sarb Giddey with the high temperature furnace for sintering the SOE ceramic tubes. Image Credit: CSIRO

CSIRO will trial the technology at BlueScope’s Port Kembla Steelworks to demonstrate the equipment at pilot scale in an industrial environment.

CSIRO’s tubular solid oxide electrolysis (SOE) technology efficiently produces hydrogen by electrolysing water using a combination of heat and electricity and promises to significantly reduce hydrogen production costs and industry emissions through process efficiencies.

The International Energy Agency estimates demand for hydrogen is expected to increase 138 per cent by 2030, but high production costs and energy inputs are key challenges for producing green hydrogen.

Dr Sarb Giddey, lead scientist on hydrogen research at CSIRO, said the development of tubular SOE technology at CSIRO is a key project aimed at producing more affordable and efficient hydrogen to help industry dramatically reduce emissions.

“CSIRO’s SOE technology has the potential to produce hydrogen at a higher efficiency and lower cost for integration with industrial processes,” Dr Giddey said.

“It allows industrial waste heat to be integrated back into the industrial processes, which decreases the electrical energy required to produce hydrogen or syn-gas by up to 30 per cent.

“It’s great news for industry, because integrating the hydrogen product back into industrial processes onsite also eliminates storage and transport costs while drastically reducing the use of fossil fuels in the industrial process,” Dr Giddey said.

The hydrogen product can be used as a feedstock for producing chemicals including ammonia, petrochemical, methanol, dimethyl ether, sustainable fuels and has applications in low emission steelmaking and heavy transport. Being free of platinum group metals and nickel also reduces reliance on international supply chains.

Hadean Energy will have exclusive rights over CSIRO’s SOE technology.

The trial with BlueScope will commence in April 2024. Integration aspects and other findings from the trial will help to demonstrate the technology at a higher scale and confirm the technical robustness of the equipment.

Chief Executive Australian Steel Products, Tania Archibald, said BlueScope supports the trial project as it aligns with their sustainability objectives.

“SOE has the potential to dramatically reduce the cost of hydrogen for low emissions steelmaking. The improved efficiency of SOE systems reduces energy consumption and reduces the electrical infrastructure required by electrolysers.” Ms Archibald said.

RFC Ambrian manages a decarbonisation technology fund targeting early-stage investments in emerging technologies with the potential to decarbonise high emissions industries.

Stefan Skorut, RFC Ambrian’s CIO, said the technology is well placed to address the existing industrial hydrogen market which is currently almost 100 per cent derived from fossil fuels.

“While SOE is the most efficient method of electrolysis, green hydrogen and synthetic fuels will remain uneconomic unless we address the scalability and cost of electrolysers,” Mr Skorut said.

“CSIRO’s tubular SOE technology represents a step change improvement across these metrics.”

RFC Ambrian has previously partnered with CSIRO to co-found other successful ventures including Chrysos Corporation, Nextore, and MRead.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.